Table 1 Baseline characteristics of participants in REPAIR-PD (n = 13)
Baseline Participant Demographics | |
|---|---|
Age (years) | 65.9 ± 7.8 |
Sex (% Male) | 54% |
Race/ethnicity, non-Hispanic White (%) | 92% |
Age at diagnosis (years) | 64.5 ± 8.1 |
Time from diagnosis at enrollment (months) | 17.2 ± 8.8 |
MMSE | 28.8 ± 1.3 |
MDS UPDRS Part I | 4.8 ± 3.4 |
MDS UPDRS Part II | 3.0 ± 2.6 |
MDS UPDRS Part III | 20.5 ± 8.1 |
MDS UPDRS Part IV | 1.0 ± 1.5 |
MDS UPDRS Total | 29.4 ± 9.3 |
Average Levodopa Dose (in IR equivalents, mg) | 532 ± 267 |
# of patients on Carbidopa/Levodopa only | 9 (70%) |
# of patients on MAO-B inhibitor (rasagiline) | 3 (23%) |
# of patients on dopamine agonist (ropinirole) | 1 (7.7%) |